Presentation is loading. Please wait.

Presentation is loading. Please wait.

B. Sicilia, F. Arribas, J. Nerín, C. López Miguel, R. Vicente, F

Published byJanice Park Modified over 6 years ago

Similar presentations

Presentation on theme: "B. Sicilia, F. Arribas, J. Nerín, C. López Miguel, R. Vicente, F"— Presentation transcript:

1 Risk factors for ulcerative colitis: A population-based, case–control study in Spain 
B. Sicilia, F. Arribas, J. Nerín, C. López Miguel, R. Vicente, F. Gomollón  Journal of Crohn's and Colitis  Volume 2, Issue 2, Pages (June 2008) DOI: /j.crohns Copyright © 2008 European Chrohn's and Colitis Organisation Terms and Conditions

2 Figure 1 Comparing “smoking” between cases and controls. Smoker: actually smoking. Ex smoker: actually non-smoker but smoking during some of the 10 previous years. Never smoker: actually non-smoker or the 10 previous years. Journal of Crohn's and Colitis 2008 2, DOI: ( /j.crohns ) Copyright © 2008 European Chrohn's and Colitis Organisation Terms and Conditions

Download ppt "B. Sicilia, F. Arribas, J. Nerín, C. López Miguel, R. Vicente, F"

Similar presentations

Active Crohn's disease is associated with low vitamin D levels

Active Crohn's disease is associated with low vitamin D levels
High and increasing prevalence of inflammatory bowel disease in Finland with a clear North–South difference  Airi Jussila, Lauri J. Virta, Veikko Salomaa,

High and increasing prevalence of inflammatory bowel disease in Finland with a clear North–South difference  Airi Jussila, Lauri J. Virta, Veikko Salomaa,
The requirements and barriers to successful transition of adolescents with inflammatory bowel disease: Differing perceptions from a survey of adult and.

The requirements and barriers to successful transition of adolescents with inflammatory bowel disease: Differing perceptions from a survey of adult and.
The risk of lymphoma and immunomodulators in patients with inflammatory bowel diseases: Results from a population-based cohort in Eastern Europe  Peter.

The risk of lymphoma and immunomodulators in patients with inflammatory bowel diseases: Results from a population-based cohort in Eastern Europe  Peter.
Risk of colorectal cancer and small bowel adenocarcinoma in Crohn's disease: A population-based study from western Hungary 1977–2008  Peter Laszlo Lakatos,

Risk of colorectal cancer and small bowel adenocarcinoma in Crohn's disease: A population-based study from western Hungary 1977–2008  Peter Laszlo Lakatos,
IBD in the elderly population: Results from a population-based study in Western Hungary, 1977���2008  Peter Laszlo Lakatos, Gyula David, Tunde Pandur,

IBD in the elderly population: Results from a population-based study in Western Hungary, 1977���2008  Peter Laszlo Lakatos, Gyula David, Tunde Pandur,
How do psychological variables influence coping strategies in inflammatory bowel disease?  Marta Iglesias-Rey, Manuel Barreiro-de Acosta, Francisco Caamaño-Isorna,

How do psychological variables influence coping strategies in inflammatory bowel disease?  Marta Iglesias-Rey, Manuel Barreiro-de Acosta, Francisco Caamaño-Isorna,
Serta Kılınçalp, Akif Altınbaş, Ömer Başar, Murat Deveci, Osman Yüksel 

Serta Kılınçalp, Akif Altınbaş, Ömer Başar, Murat Deveci, Osman Yüksel 
Does the endoscopic appearance of the ileocecal valve suggest the severity of Crohn's disease in the terminal ileum?  Tamás Molnár, Klaudia Farkas, Ferenc.

Does the endoscopic appearance of the ileocecal valve suggest the severity of Crohn's disease in the terminal ileum?  Tamás Molnár, Klaudia Farkas, Ferenc.
Dermatological adverse reactions during anti-TNF treatments: Focus on inflammatory bowel disease  Giammarco Mocci, Manuela Marzo, Alfredo Papa, Alessandro.

Dermatological adverse reactions during anti-TNF treatments: Focus on inflammatory bowel disease  Giammarco Mocci, Manuela Marzo, Alfredo Papa, Alessandro.
Serological markers are associated with disease course in ulcerative colitis. A study in an unselected population-based cohort followed for 10 years 

Serological markers are associated with disease course in ulcerative colitis. A study in an unselected population-based cohort followed for 10 years 
Anti-tumor necrosis factor-α induced systemic lupus erythematosus in a patient with metastatic Crohn's disease—what is the role of anti-TNF antibody? 

Anti-tumor necrosis factor-α induced systemic lupus erythematosus in a patient with metastatic Crohn's disease—what is the role of anti-TNF antibody? 
Concurrent small bowel adenocarcinoma and carcinoid tumor in Crohn's disease — Case report and literature review  Doron Boltin, Zohar Levi, Marisa Halpern,

Concurrent small bowel adenocarcinoma and carcinoid tumor in Crohn's disease — Case report and literature review  Doron Boltin, Zohar Levi, Marisa Halpern,
YouTube® and inflammatory bowel disease

YouTube® and inflammatory bowel disease
A case report: Ulcerative colitis, treatment with an antibody against tumor necrosis factor (infliximab), and subsequent liver necrosis  Urpo Kinnunen,

A case report: Ulcerative colitis, treatment with an antibody against tumor necrosis factor (infliximab), and subsequent liver necrosis  Urpo Kinnunen,
Incidence of ulcerative colitis and Crohn's disease in Danish children: Still rising or levelling out?  Christian Jakobsen, Vibeke Wewer, Frederikke Urne,

Incidence of ulcerative colitis and Crohn's disease in Danish children: Still rising or levelling out?  Christian Jakobsen, Vibeke Wewer, Frederikke Urne,
Liver abscess of the caudate lobe due to Staphylococcus aureus in an ulcerative colitis patient: First case report  Andreia Albuquerque, Fernando Magro,

Liver abscess of the caudate lobe due to Staphylococcus aureus in an ulcerative colitis patient: First case report  Andreia Albuquerque, Fernando Magro,
Serological markers are associated with disease course in ulcerative colitis. A study in an unselected population-based cohort followed for 10 years 

Serological markers are associated with disease course in ulcerative colitis. A study in an unselected population-based cohort followed for 10 years 
Primary biliary cirrhosis developing in a patient with Crohn's disease during the course of infliximab treatment: The first case in the literature  Gurhan.

Primary biliary cirrhosis developing in a patient with Crohn's disease during the course of infliximab treatment: The first case in the literature  Gurhan.
Preoperative use of anti-TNF therapy and postoperative complications in inflammatory bowel diseases: A meta-analysis  Vincent Billioud, Alexander C. Ford,

Preoperative use of anti-TNF therapy and postoperative complications in inflammatory bowel diseases: A meta-analysis  Vincent Billioud, Alexander C. Ford,

Similar presentations

Ads by Google